Training
11 - 12 April 2019
3 - 4 June 2016
Individualized Medicine in Infectious Diseases: a Practical Approach
13 - 16 April 2016
Population Modeling and Dose Optimization with Pmetrics and BestDose: Antimicrobial Applications
19 - 21 November 2015
5 - 6 November 2015
2 - 3 October 2014
6 - 8 October 2014
16 - 18 September 2014
4 - 6 July 2014
Bringing PK and PD in Fungal Infections into the Clinic
Course Coordinators
• Roger Brüggemann, Nijmegen, The Netherlands
• Joseph Meletiadis, Athens, Greece
• Ursula Theuretzbacher, Vienna, Austria
• Andrew J. Ullmann, Würzburg, Germany
Course Objectives
• To learn PK/PD principles of antifungal therapy
• To learn the pharmacokinetic differences among different patient populations
• To understand resistance mechanisms of fungi and their impact on antifungal treatment
• To learn how to use in vitro susceptibility data and to understand what breakpoints mean
• To explore the utility of therapeutic drug monitoring, the principles of dose adjustment, and how to optimize the therapy
• To understand the different clinical approaches of antifungal therapy and prophylaxis
• To learn how to apply antifungal stewardship in your centre
Faculty Members
| Roger Brüggemann, Nijmegen, The Netherlands | Joseph Meletiadis, Athens, Greece |
| Werner Heinz, Würzburg, Germany | Johan Mouton, Nijmegen, The Netherlands |
| William Hope, Liverpool, United Kingdom | Livio Pagano, Rome, Italy |
| Christine Imbert, Poitiers, France | Maurizio Sanguinetti, Rome, Italy |
| Evelyne Jacqz-Agrain, Paris, France | Ursula Theuretzbacher, Vienna, Austria |
| Johan Maertens, Leuven, Belgium | Andrew J. Ullmann, Würzburg, Germany |
| Oscar Marchetti, Lausanne, Switzerland | Paul Verweij, Nijmegen, The Netherlands |
Oct 8-11, 2012
The ESCMID PK/PD Study Group organized a 4-day technical workshop in Athens, Greece, Oct 8-11, 2012
A Statistical Approach to PK/PD Analysis in Practice
Course Coordinators
• Eleftheria Mavridou, Nijmegen, NL
• Joseph Meletiadis, Athens, GR
• Johan W. Mouton, Nijmegen, NL
Course Objectives
• Provide guidance on how to implement adequate statistical analysis to evaluate the pharmacokinetic and pharmacodynamic data
• Understand PK/PD indices, principles of CART analysis and how to apply these to establish
clinical breakpoints
• Learn how to perform univariate and multivariate analysis, linear and nonlinear regression
analysis, including the ins and outs of the Emax model
• To clarify the principles of pharmacokinetic parameters (peak and trough levels, volume of
distribution, area under the concentration curve) and the factors that affect them
• Explain how to perform compartmental and non-compartmental pharmacokinetic analysis
• Understand how to measure and analyse drug combination effects and how to determine
synergy and antagonism, including the Greco and Bliss models
• Perform analysis with different software programs
Faculty Members
• Saiden Abbas, Nijmegen, NL
• Roger Brüggemann, Nijmegen, NL
• William Hope, Manchester, UK
• Pavol Jancura, Nijmegen, NL
• Klaus Skovbo Jensen, Copenhagen, DK
• Eleftheria Mavridou, Nijmegen, NL
• Joseph Meletiadis, Athens, GR
• Johan W. Mouton, Nijmegen, NL
• Anouk E. Muller, Rotterdam, NL
• Ursula Theuretzbacher, Vienna, AT
Workshops
2019 - ASM MICROBE WORKSHOP
ASM microbe Workshop 2019
Thursday, June 20 2019 at Mocscone Center, San Francisco, CA, USA, 12:30PM - 4:00PM
Introduction to Pharmacokinetics/Pharmacodynamics: a Basic Primer
| Workshop Moderator Brian Tsuji; Univ. at Buffalo, Buffalo, NY |
| Workshop Moderator Roger Nation; Monash Univ., Parkville, AL, Australia |
| PK-PD Relationships of Antimicrobials: An introduction Brian Tsuji; Univ. at Buffalo, Buffalo, NY |
| Concepts in Antimicrobial PK-PD: Linking to Humans Elizabeth Lakota; Inst. for Clinical Pharmacodynamics, Inc., Schenectady, NY |
| Use of In-vitro Models to Elucidate the PK-PD Driver of Antimicrobial Activity Roger Nation; Monash Univ., Parkville, AL, Australia |
| Animal Models and Their Use in Defining PK-PD Relationships Vincent Tam; Univ. of Houston, Houston, TX |
2018 - ISID WORKSHOP
ISID Workshop 2018
18th Congress of the International Society for Infectious Diseases
Saturday, March 3 2018 at Sheraton Buenos Aires Hotel & Convention Center, Buenos Aires, Argentina, 5:00PM - 6:00PM
Workshop session titled "Optimized Antibiotic Use"
|
Individualized Antibiotics Use - an Introduction |
| Bring your tablet – Individualized Antibiotic Dosing with Interactive Case Studies Sebastian Wicha; University of Hamburg, Hamburg, Germany |
2015 - ICAAC WORKSHOPS
ICAAC Workshops 2015
Thursday, September 17 at San Diego Convention Center, CA, USA, 8:30AM - 4:30PM
Workshop.55-01.Introduction to Pharmacokinetics/Pharmacodynamics
2014 - ICAAC WORKSHOPS
ICAAC Workshops 2014
Friday Sept. 5. 2014 at the Walter E. Washington Convention Center, Washington DC, USA, 8:30AM - 4:30PM
Workshop.54-01.Introduction to Pharmacokinetics/Pharmacodynamics
Workshop.54-03.Application of Pharmacokinetic/Pharmacodynamic Models
| Workshop Convener Sujata M. Bhavnani, PharmD, MS - Vice President ICPD, Latham, NY. |
| Workshop Convener Alan Forrest, Pharm D - Research Professor and Senior Director of Pharmacometrics Univ. at Buffalo and Inst. of Clin. Pharmacodynamics, Buffalo, NY. |
| Use of Population Pharmacokinetic Modeling in Therapeutic Drug Monitoring Alexander A. Vinks, PharmD, PhD - Professor Univ. of Cincinnati, Cincinnati, OH. |
| Monte Carlo Simulation: Application to Dose Selection and Identification of Susceptibility Breakpoints Sujata M. Bhavnani, Pharm.D., M.S. - Vice President ICPD, Latham, NY. |
| Modeling and Prediction of Anti-Infective Activity Alan Forrest, Pharm D - Research Professor and Senior Director of Pharmacometrics Univ. at Buffalo and Inst. of Clin. Pharmacodynamics, Buffalo, NY. |
| Resistant Breakpoint Determination Alasdair MacGowan, MD - Professor North Bristol NHS Trust & Univ. of Bristol, Bristol, United Kingdom. |
| Pharmacokinetics/Pharmacodynamics to Characterize and Overcome Resistance George Drusano, MD - Professor and Director Univ. of Florida, Orlando, FL. |
Workshop.54-02.Clinical Pharmacokinetics/Pharmacodynamics
| Workshop Convener Vincent H. Tam, PharmD - Professor Univ. of Houston Coll. of Pharmacy, Houston, TX. |
| Workshop Convener Johan Mouton, MD, PhD - Professor Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands. |
| Clinical Application of Pharmacokinetics and Pharmacodynamics Vincent H. Tam, PharmD - Professor Univ. of Houston Coll. of Pharmacy, Houston, TX. |
| Combination Therapy Johan Mouton, MD, PhD - Professor Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands. |
| Clinical Considerations of Obesity Manjunath Pai Albany Coll. of Pharmacy and Hlth. Sci., Albany, NY |
| Dosing in Special Patient Populations Markus Zeitlinger, MD - Associate Professor Med. Univ. Vienna, Vienna, Austria. |
| Individualized Dosing and Therapeutic Drug Monitoring Thomas P. Lodise JR Albany Coll. of Pharmacy and Hlth. Sci., Albany, NY.. |
Workshop.54-04.Pharmacokinetic/Pharmacodynamic Modeling of Anti-Infective Agents
| Workshop Convener David R. Andes, MD - Professor Univ. of Wisconsin, Madison, WI. |
| Workshop Convener George Drusano, MD - Professor and Director Univ. of Florida, Gainesville, FL. |
| In Vitro Dynamic Models for Antibiotic Pharmacokinetics-Pharmacodynamics Warren E. Rose Univ. of Wisconsin, Madison, WI |
| Hollow Fiber System George Drusano, MD - Professor and Director Univ. of Florida, Gainesville, FL |
| Animal Models for Pharmacokinetics/Pharmacodynamics David R. Andes, MD - Professor Univ. of Wisconsin-Madison, Madison, WI |
| A Pharmacometric-Based Approach to Facilitate Critically Needed Development of New Antibiotics Sujata M. Bhavnani, PharmD, MS - Vice President ICPD, Latham, NY |
| Mathematical Modeling: Software Choices Jurgen B. Bulitta Monash Univ. and SUNY-Buffalo, Parkville, Australia |
2013 - ICAAC WORKSHOPS
ICAAC Workshops 2013
Monday, September 9, 2013 at the Colorado Convention Center, Denver, USA, 8:30AM - 4:30PM
Workshop.53-01.Introduction to Pharmacokinetics/Pharmacodynamics
Workshop.53-03.Application of Pharmacokinetic/Pharmacodynamic Models
| Workshop Convener Sujata M. Bhavnani, PharmD, MS - Vice President ICPD, Latham, NY. |
| Workshop Convener Alan Forrest, Pharm D - Research Professor and Senior Director of Pharmacometrics Univ. at Buffalo and Inst. of Clin. Pharmacodynamics, Buffalo, NY. |
| Use of Population Pharmacokinetic Modeling in Therapeutic Drug Monitoring Alexander A. Vinks, PharmD, PhD - Professor Univ. of Cincinnati, Cincinnati, OH. |
| Predicting Pharmacokinetic Variability Using Stochastic Simulation Sujata M. Bhavnani, Pharm.D., M.S. - Vice President ICPD, Latham, NY. |
| Modeling and Prediction of Anti-Infective Activity Alan Forrest, Pharm D - Research Professor and Senior Director of Pharmacometrics Univ. at Buffalo and Inst. of Clin. Pharmacodynamics, Buffalo, NY. |
| Resistant Breakpoint Determination Alasdair MacGowan, MD - Professor North Bristol NHS Trust & Univ. of Bristol, Bristol, United Kingdom. |
| Pharmacokinetics/Pharmacodynamics to Characterize and Overcome Resistance George Drusano, MD - Professor and Director Univ. of Florida, Orlando, FL. |
Workshop.53-02.Clinical Pharmacokinetics/Pharmacodynamics
| Workshop Convener Vincent H. Tam, PharmD - Professor Univ. of Houston Coll. of Pharmacy, Houston, TX. |
| Workshop Convener Johan Mouton, MD, PhD - Professor Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands. |
| Clinical Application of Pharmacokinetics and Pharmacodynamics Vincent H. Tam, PharmD - Professor Univ. of Houston Coll. of Pharmacy, Houston, TX. |
| Combination Therapy Johan Mouton, MD, PhD - Professor Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands. |
| Dosing in Special Patient Populations Markus Zeitlinger, MD - Associate Professor Med. Univ. Vienna, Vienna, Austria. |
| Individualized Dosing and Therapeutic Drug Monitoring Jason A. Roberts, PharmD, PhD - Consultant Clinical Pharmacist Royal Brisbane and Women’s Hosp. & Univ. of Queensland, Brisbane, Australia. |
| Clinical Study Design Based Upon Pharmacokinetics/Pharmacodynamics Sujata M. Bhavnani, Pharm.D., M.S. - Vice President ICPD, Latham, NY. |
Workshop.53-04.Pharmacokinetics/Pharmacodynamics in Non-Bacterial Infections
| Workshop Convener David R. Andes, MD - Professor Univ. of Wisconsin, Madison, WI. |
| Workshop Convener George Drusano, MD - Professor and Director Univ. of Florida, Orlando, FL. |
| Anti-Fungal Pharmacokinetics/Pharmacodynamics David R. Andes, MD - Professor Univ. of Wisconsin, Madison, WI. |
| Anti-Tuberculosis Pharmacokinetics/Pharmacodynamics Tawanda Gumbo, MD - Associate Professor of Medicine UT Southwestern Med. Ctr., Dallas, TX. |
| Anti-Viral Pharmacokinetics/Pharmacodynamics George Drusano, MD - Professor and Director Univ. of Florida, Orlando, FL. |
| Anti-Malaria Pharmacokinetics/Pharmacodynamics Nicholas J. White, MD, FRS - Professor of Tropical Medicine Mahidol Univ. and Oxford Univ., Bangkok, Thailand. |
2012 - ICAAC WORKSHOPS - San Francisco
ICAAC Workshops 2012
Saturday, September 8, 2012, San Francisco, USA
Moscone Center (Esplanade Ballrooms)Workshop 01 (Derendorf/Mouton) Basics of Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents
| 8:30 - 8:40 am |
Conveners |
Introduction |
| 8:40 – 9:10 am |
H. Derendorf |
Introduction to PK/PD + discussion |
| 9:10 – 9:40 am |
J. Mouton |
PK/PD indices + discussion |
| 9:40 - 10:10 am |
U. Theuretzbacher |
Protein Binding/Tissue Distribution + discussion |
| 10:10 - 10:30 am |
Break |
|
| 10:30 – 11:00 am |
R. Nation |
In vitro models + discussion |
| 11:00 - 11:30 am |
W. Craig |
Animal models + discussion |
| 11:30 – 12:00 am |
A. MacGowan |
In vitro resistance + discussion |
Workshop 02 (Mouton/Theuretzbacher) Clinical Relevance of Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents
| 1:00 – 1:10 pm |
Conveners |
Introduction |
| 1:10 – 1:40 pm |
J. Mouton |
Clinical applications of PK/PD + discussion |
| 1:40 – 2:10 pm |
M. Zeitlinger |
Drug exposure at infection site + discussion |
| 2:10 – 2:40 pm |
S. Bhavnani |
Clinical study design based on PK/PD + discussion |
| 2:40 – 3:00 pm |
Break |
|
| 3:00 – 3:30 pm |
U. Theuretzbacher |
Clinical resistance + discussion |
| 3:30 – 4:00 pm |
D. Andes |
PK/PD of antifungals + discussion |
| 4:00 – 4:30 pm |
P. Tulkens |
Dosing in specific situations + discussion |
Workshop 51-03 (Tam/Vinks) Introduction to PK/PD Modeling of Anti-Infective Agents
| 8:30 - 8:40 am |
Conveners |
Introduction |
| 8:40 – 9:10 am |
A. MacGowan |
Approach to clinical breakpoints + discussion |
| 9:10 – 9:40 am |
V. Tam |
PK/PD modeling of resistance + discussion |
| 9:40 - 10:10 am |
J. Crandon |
PK/PD approaches in drug development + discussion |
| 10:10 - 10:30 am |
Break |
|
| 10:30 – 11:00 am |
A. Vinks |
Population PK/PD modeling of anti-infective agents + discussion |
| 11:00 - 11:30 am |
A. Forrest |
Modeling of anti-infective activity + discussion |
| 11:30 – 12:00 am |
S. Bhavnani |
Monte Carlo Simulations + discussion |
Workshop 51-04 (Drusano/Derendorf) Advanced PK/PD Modeling of Anti-Infective Agents with Practical Examples
| 1:00 – 1:10 pm |
Conveners |
Introduction |
| 1:10 – 1:55 pm |
H. Derendorf |
PK/PD based on kill curves + discussion |
| 1:55 – 2:40 pm |
A. Forrest |
Modeling of anti-infective activity + discussion |
| 2:40 – 3:00 pm |
Break |
|
| 3:00 – 3:45 pm |
G. Drusano |
PK/PD in drug development + discussion |
| 3:45 – 4:30 pm |
J. Bulitta |
PK/PD models of resistance + discussion |
